✦ LIBER ✦

Effects of Losartan-based therapy on the incidence of end-stage renal disease and associated costs in type 2 diabetes mellitus: A retrospective cost-effectiveness analysis in the United Kingdom

✍ Scribed by Jiten Vora; George Carides; Paul Robinson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Losartan and the United States costs of

✍ Alexander, Charles M.; Lyle, Paulette A.; Keane, William F.; Carides, George W.; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

PCV34 THE COST-EFFECTIVENESS OF ALISKIRE

✍ JL Palmer; VC Munk; R Kotchie; G Vincze; Charney k; D Tucker; L Annemans 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

DB1 ESTIMATING THE LONG-TERM CLINICAL AN

✍ HT Smith; WJ Valentine; KS Boye; A Kalsekar; C Pratoomsoot 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE

✍ Clarke, PM; Glasziou, P; Alexander, J; Chalmers, J; Patel, A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PDB55 Estimating the Cost-Effectiveness

✍ B. Curtis; R. Pollock; J. Smith-Palmer; W. Valentine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB